Three veterans of the medical market have created a company that wants to buy shares in biotechnology companies, drive them through painstaking clinical trials and sell them for a profit. They have people, resources and some money to do so. But most of all, they know how to do it
".....Orphinic is not a sum but a multiplication of our experiences...."
Our co-founders Adam Kruszewski, Artur Plonowski and Jaroslaw Leszczyszyn in the latest issue Forbes Polska
